Drug Topics October 12, 2023
Lauren Biscaldi, MS, Managing Editor

There has been growing evidence around the potential for the success of remote diabetes care and CGM technology use.

A comprehensive care model, inclusive of telehealth-delivered diabetes care with continuous glucose monitor (CGM) use can improve patient outcomes in type 1 and type 2 diabetes, according to research results published in JAMA Network Open.1

There has been growing evidence around the potential for the success of remote diabetes care and CGM technology use. Therefore, researchers sought to evaluate a model that could “minimize adoption-limiting factors” such as geography and access to specialty care” for adults with type 1 or type 2 diabetes.

Between August 24, 2020 and May 26, 2022, researchers conducted the Virtual Diabetes Specialty Clinic (VDiSC) study to...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Patient / Consumer, Provider, Technology, Telehealth, Wearables
Related Articles:
AHA, others urge Congress to act on alternative payment models, avoid physician payment cut
Are telehealth visits for pediatric primary care associated with higher rates of health care utilization?
Hospital recovery at risk if Congress doesn’t extend telehealth, Fitch Ratings says
End of home health, telehealth coverage threatens hospitals' recovery: Fitch
Election Implications for Telehealth, Health Equity, AI and Life Sciences

Share This Article